← Leaderboards
Bhaumik B Patel
Va Veterans Administration Hospital
$0
Attributed
$0
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $0 · FY2012–25$1$1$1$0$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
VA$0 · 3
By mechanism
I01$0 · 3
Top collaborators
No co-investigators on record.
Most similar at Va Veterans Administration Hospital
Same institution · by research overlap
- William M Pandak$824,334
Others in their field
Top investigators on “Cancer Stem Cell”
- David Heimbrook · Leidos Biomedical Research, Inc.$162,492,362
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,653,178
- Mary M Horowitz · Medical College Of Wisconsin$154,320,720
- Todd A Alonzo · University Of Colorado Denver/Hsc Denver$62,800,467
- Timothy J Eberlein · Washington University$49,931,668
- Elaine Fuchs · University Of Chicago$38,905,243
Research focus
Cancer Stem CellIn VivoColorectal CancerCancer CellSelf-RenewalPlayColonCellsColon CarcinomaMalignant NeoplasmsIn VitroRegulationPhenotypeSignal TransductionFluorouracilOxaliplatinXenograft ProcedureMolecularChemotherapyPharmaceutical PreparationsCancer TherapyStemColorectal Cancer TreatmentPathway Interactions
Grant awards (20)
Unique Non-Saccharide Mimetics of Sulfated Glycosaminoglycan Target Colon Cancer Stem Cells$0
I01 · FY2025 · VA · contact PI
StarD5, a protein that translocates cholesterol to the plasma membrane, is a novel target for Colon Cancer$0
I01 · FY2025 · VA · contact PI
StarD5, a protein that translocates cholesterol to the plasma membrane, is a novel target for Colon Cancer$0
I01 · FY2024 · VA · contact PI
Unique Non-Saccharide Mimetics of Sulfated Glycosaminoglycan Target Colon Cancer Stem Cells$0
I01 · FY2024 · VA · contact PI
Unique Non-Saccharide Mimetics of Sulfated Glycosaminoglycan Target Colon Cancer Stem Cells$0
I01 · FY2023 · VA · contact PI
StarD5, a protein that translocates cholesterol to the plasma membrane, is a novel target for Colon Cancer$0
I01 · FY2023 · VA · contact PI
StarD5, a protein that translocates cholesterol to the plasma membrane, is a novel target for Colon Cancer$0
I01 · FY2022 · VA · contact PI
Unique Non-Saccharide Mimetics of Sulfated Glycosaminoglycan Target Colon Cancer Stem Cells$0
I01 · FY2022 · VA · contact PI
Unique Non-Saccharide Mimetics of Sulfated Glycosaminoglycan Target Colon Cancer Stem Cells$0
I01 · FY2021 · VA · contact PI
StarD5, a protein that translocates cholesterol to the plasma membrane, is a novel target for Colon Cancer$0
I01 · FY2021 · VA · contact PI
StarD5, a protein that translocates cholesterol to the plasma membrane, is a novel target for Colon Cancer$0
I01 · FY2020 · VA · contact PI
Inhibition of IGF-1R: A Therapeutic Strategy for Colon Cancer Stem-like Cells$0
I01 · FY2019 · VA · contact PI
Inhibition of IGF-1R: A Therapeutic Strategy for Colon Cancer Stem-like Cells$0
I01 · FY2018 · VA · contact PI
Inhibition of IGF-1R: A Therapeutic Strategy for Colon Cancer Stem-like Cells$0
I01 · FY2017 · VA · contact PI
Inhibition of IGF-1R: A Therapeutic Strategy for Colon Cancer Stem-like Cells$0
I01 · FY2016 · VA · contact PI
Inhibition of IGF-1R: A Therapeutic Strategy for Colon Cancer Stem-like Cells$0
I01 · FY2015 · VA · contact PI
Inhibition of IGF-1R: A Therapeutic Strategy for Colon Cancer Stem-like Cells$0
I01 · FY2014 · VA · contact PI
Inhibition of IGF-1R: A Therapeutic Strategy for Colon Cancer Stem-like Cells$0
I01 · FY2013 · VA · contact PI
Novel NMDA Antagonists to Treat Stroke$0
I01 · FY2013 · VA · contact PI
Inhibition of IGF-1R: A Therapeutic Strategy for Colon Cancer Stem-like Cells$0
I01 · FY2012 · VA · contact PI